Randomized Trialhigh evidence
Efficacy and Safety of NFL-101 as a Smoking Cessation Therapy: A Randomized Phase II Clinical Trial CESTO2.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·March 24, 2026·PMID 40884488
Why it mattersNFL-101 represents a novel immunomodulatory approach to smoking cessation requiring only two injections, potentially improving adherence over daily medications. The signal of efficacy, craving reduction, and favorable safety profile support further investigation in a phase III trial.

The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled